| Prevalence and characteristics of the metabolic syndrome in primary aldosteronism. | |
| | |
MedLine Citation:
|
PMID: 16291704 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
CONTEXT: Patients with hypertension have a high prevalence of concurrent metabolic abnormalities, including obesity, dyslipidemia, and hyperglycemia. Clustering of these cardiovascular risk factors, defined as metabolic syndrome, causes a more pronounced target organ damage. Aldosterone excess has been found to be associated with glucose disorders and may contribute to cardiovascular damage. OBJECTIVE: The aim of our study was to assess the prevalence and the characteristics of the metabolic syndrome in a group of patients with hypertension due to primary aldosteronism compared with patients with essential hypertension. METHODS: The National Cholesterol Education Program Adult Treatment Panel III definition of the metabolic syndrome was used. Eighty-five patients with primary aldosteronism and 381 patients with essential hypertension were studied. Most patients were not receiving antihypertensive therapy during the investigation. RESULTS: Blood glucose and systolic blood pressure were higher (P < 0.05 and P < 0.01, respectively) and duration of hypertension was longer (P < 0.05) in primary aldosteronism than in essential hypertension. The prevalence of metabolic syndrome was higher in primary aldosteronism than in essential hypertension (41.1% vs. 29.6%; P < 0.05). Distribution of single components of the metabolic syndrome other than hypertension showed a higher prevalence of hyperglycemia in primary aldosteronism than in essential hypertension (27.0% vs. 15.2%; P < 0.05). CONCLUSIONS: Our findings confirm a negative effect of aldosterone excess on glucose metabolism and suggest that the recently reported higher rates of cardiovascular events in primary aldosteronism than in essential hypertension might be due to increased prevalence of the metabolic syndrome in the former condition. |
| | |
Authors:
|
Francesco Fallo; Franco Veglio; Chiara Bertello; Nicoletta Sonino; Paolo Della Mea; Mario Ermani; Franco Rabbia; Giovanni Federspil; Paolo Mulatero |
Related Documents
:
|
2970434 - Dietary sodium change in primary aldosteronism. atrial natriuretic factor, hormonal, an... 20093814 - Aldosterone in uremia - beyond blood pressure. 3326694 - Hemodynamic and neurohumoral factors in the response of hypertensives to hydrochlorothi... 3520094 - Blood pressure control in normotensive members of hypertensive families. 12372574 - Coronary flow reserve and myocardial diastolic dysfunction in arterial hypertension. 1408474 - Arterial oxygen tension threshold range for the onset of arousal and breathing in fetal... |
Publication Detail:
|
Type: Journal Article Date: 2005-11-15 |
Journal Detail:
|
Title: The Journal of clinical endocrinology and metabolism Volume: 91 ISSN: 0021-972X ISO Abbreviation: J. Clin. Endocrinol. Metab. Publication Date: 2006 Feb |
Date Detail:
|
Created Date: 2006-02-07 Completed Date: 2006-03-14 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0375362 Medline TA: J Clin Endocrinol Metab Country: United States |
Other Details:
|
Languages: eng Pagination: 454-9 Citation Subset: AIM; IM |
Affiliation:
|
Department of Medical and Surgical Sciences, Universita di Padova, Via Ospedale 105, 35128 Padua, Italy. francesco.fallo@unipd.it |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Adult Aged Aged, 80 and over Blood Glucose / metabolism Blood Pressure / physiology Cholesterol, HDL / blood Female Humans Hyperaldosteronism / blood, complications*, metabolism Hypertension / blood, complications*, metabolism Male Metabolic Syndrome X / blood, complications*, metabolism Middle Aged Prospective Studies Triglycerides / blood |
| Chemical | |
Reg. No./Substance:
|
0/Blood Glucose; 0/Cholesterol, HDL; 0/Triglycerides |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Gestational age-dependent up-regulation of prostaglandin D synthase (PGDS) and production of PGDS-de...
Next Document: Characterization of insulin secretion and resistance in type 2 diabetes of adolescents.